HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): David A. Heimansohn Robert J. Robison John M. Paris, III Robert G. Matheny Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Heimansohn, D. A. Articles by Shaar, C. J. Search for Related Content PubMed PubMed Citation Articles by Heimansohn, D. A. Articles by Shaar, C. J. Related Collections Related Articles

Ann Thorac Surg 1997;64:1231-1236
© 1997 The Society of Thoracic Surgeons

---

Original Articles: Cardiovascular

Routine Surveillance Endomyocardial Biopsy: Late Rejection After Heart Transplantation

Department of Cardiovascular/Thoracic Surgery, and Transplant Department, St. Vincent Hospital and Health Care Center, Indianapolis, Indiana

Background. Transplant programs use routine surveillance endomyocardial biopsies (RSEMB), which are performed at preset intervals to diagnose cardiac rejection. This retrospective study determined the incidence of graft rejection detected by RSEMB.

Methods. The records of 95 patients who underwent heart transplantation between 1987 and 1995 were reviewed. Rejection incidence was recorded for 80 patients who survived at least 30 days, with a mean follow-up of 35 months.

Results. One thousand five hundred sixteen total biopsies were performed; 1,170 were RSEMB. Four hundred seventy-five total rejection episodes occurred and 269 (56%) were diagnosed by RSEMB. Two distinct patient groups were identified. The majority (70 patients), had a decline in the incidence of rejection and no rejection episodes were identified by RSEMB after 36 months. In contrast, the high rejection group (10 patients) had a significantly higher ongoing rejection rate (p 0.04 to p 0.001) throughout their postoperative course up to 72 months.

Conclusions. The majority of our transplant patients demonstrate a decrease in rejection with time and do not require RSEMB beyond 30 months. We identified a group of patients who exhibited a higher rate of rejection and need continued RSEMB.

Related Articles

Routine Surveillance Endomyocardial Biopsy

Gulshan K. Sethi and Jack G. Copeland, III
Ann. Thorac. Surg. 1997 64: 1230. [Extract] [Full Text]

This article has been cited by other articles:

				G. K. Sethi and J. G. Copeland III Routine Surveillance Endomyocardial Biopsy Ann. Thorac. Surg., November 1, 1997; 64(5): 1230 - 1230. [Full Text]